Instadose Pharma Corp. (INSD) financial statements (2022 and earlier)

Company profile

Business Address 5500 NORTH SERVICE ROAD, SUITE 301
BURLINGTON, ON L7L 6W6
State of Incorp. NV
Fiscal Year End November 30
SIC 251 - Household Furniture (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

11/30/2021
11/30/2020
11/30/2019
11/30/2018
11/30/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 0 01
Cash and cash equivalents 0 01
Total current assets: 0 01
Noncurrent Assets
TOTAL ASSETS: 0 01
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities90111
Accounts payable90111
Due to related parties 82563312
Other undisclosed current liabilities154    
Total current liabilities:16282573413
Noncurrent Liabilities
Total liabilities:16282573413
Stockholders' equity
Stockholders' equity attributable to parent(162)(82)(57)(33)(12)
Common stock875757575
Additional paid in capital402(51)(51)(51)(51)
Accumulated deficit(568)(106)(81)(57)(34)
Stockholders' equity note, subscriptions receivable(3)   (2)
Total stockholders' equity:(162)(82)(57)(33)(12)
TOTAL LIABILITIES AND EQUITY: 0 01

Income statement (P&L) ($ in thousands)

11/30/2021
11/30/2020
11/30/2019
11/30/2018
11/30/2017
Revenues   3 
Cost of revenue   (1) 
Gross profit:   1 
Operating expenses(762)(8)24(25)(32)
Other undisclosed operating loss (18)   
Operating income (loss):(762)(26)24(24)(32)
Income (loss) from continuing operations before income taxes:(762)(26)24(24)(32)
Income tax benefit119    
Net income (loss):(643)(26)24(24)(32)
Other undisclosed net income (loss) attributable to parent181 (47)  
Net loss available to common stockholders, diluted:(462)(26)(23)(24)(32)

Comprehensive Income ($ in thousands)

11/30/2021
11/30/2020
11/30/2019
11/30/2018
11/30/2017
Net income (loss):(643)(26)24(24)(32)
Comprehensive income (loss), net of tax, attributable to parent:(643)(26)24(24)(32)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: